NCT04620109: Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment |
|
|
| Recruiting | 1 | 62 | US | KDR2-2, KDR2-2 suspension eyedrop, KDR2-2 ophthalmic suspension, Placebo | Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd, Parexel | Corneal Neovascularization | 03/21 | 06/21 | | |
